Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury
- Conditions
- Acute Kidney Injury
- Registration Number
- NCT02016053
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Brief Summary
500 patients with normal renal function will be prospectively studied and incidence, spectrum and natural history of AKI (Acute Kidney Injury) will be observed in them and in 200 patients with abnormal renal function fulfilling AKI (Acute Kidney Injury) criteria will be prospectively studied for 1 year. Also biomarkers will be studied and validated as early predictors of AKI (Acute Kidney Injury).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 450
- Group A: 500 patients of cirrhosis with normal baseline renal function will be enrolled Group B : 200 patients who present with AKI (Acute Kidney Injury) will be enrolled
- Age < 18 or > 70 years
- Preexisting Chronic Renal Disease
- Patients with obstructive uropathy.
- Cirrhosis with HCC (HepatoCellular Carcinoma).
- Advanced cardiopulmonary disease
- Pregnancy
- Patients with extrahepatic malignancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence , spectrum and natural history of Acute Kidney Injury in patients with cirrhosis 1 Year Incidence is defined as No. of AKI (Acute Kidney Injury) patients during the follow up period of 1 year.
Spectrum is defined as Grading of AKIN (Acute Kidney Injury Network) 1,2,3 in different child status (Child A,Child B and Child C) at the end .
Natural History is defined as Occurrence of AKI (Acute Kidney Injury) and its recovery during the follow up period of 1 year.
- Secondary Outcome Measures
Name Time Method To study predictive value of Cystatin C to determine progression or resolution of Acute Kidney Injury 1 Years To study predictive value of Cystatin C in comparison to serum creatinine as early predictor of development and outcome of AKI in a cohort of Cirrhotics. 1 Years
Trial Locations
- Locations (1)
Institute of Liver & Biliary Sciences
🇮🇳New Delhi, Delhi, India